Emerging Viral Diseases—The One Health Connection
March 18–19, 2014
500 Fifth Street, NW
Washington DC
DAY ONE: TUESDAY, MARCH 18, 2014
| 8:00–8:30: | Registration and continental breakfast |
| 8:30–8:45: | Welcoming remarks and overview: Drs. David A. Relman, James M. Hughes, Lonnie King |
| 8:45–9:30: |
KEYNOTE: Challenges and trends in emerging viral diseases: A global perspective
Keiji Fukuda, The World Health Organization |
| 9:30–10:00: | DISCUSSION |
| 10:00–10:30: | BREAK |
SESSION I: OVERVIEW OF EMERGING VIRAL DISEASES
Moderator: Peter Daszak
| 10:30–11:00: |
Global trends in emerging viral diseases of wildlife origin
Jonathan Sleeman, USGS National Wildlife Health Center |
| 11:00–11:30: |
The relationship between eco-social system changes, the animal–human interface and viral disease emergence
Dirk Pfeiffer, Royal Veterinary College |
| 11:30–12:00: |
Studying immunity to zoonotic diseases in the natural host—Keeping it real
John Lowenthal, CSIRO |
| 12:00–12:30: |
Emerging and reemerging viral diseases: A view from NIAID
Anthony Fauci, NIAID |
| 12:30–1:00: | DISCUSSION |
| 1:00–1:45: | LUNCH |
SESSION II: THE EMERGENCE OF A NOVEL BETACORONAVIRUS IN THE MIDDLE EAST—LOCAL, REGIONAL, AND GLOBAL IMPACTS
Moderator: Lonnie King
| 1:45–2:15: |
Human coronavirus emergence and cross-species adaptation
Ralph Baric, University of North Carolina |
| 2:15–2:45: |
Animal coronaviruses: Lessons for MERS and SARS human coronaviruses
Linda Saif, Ohio State University |
| 2:45–3:15: | BREAK |
| 3:15–3:45: |
Investigating the ecology and animal origins of MERS-CoV
Jonathan Epstein and Kevin Olival, EcoHealth Alliance |
| 3:45–4:15: |
MERS-CoV: Its epidemiology, transmissibility, pandemic potential, and prevention
Trish M. Perl, Johns Hopkins School of Medicine |
| 4:15–4:45: |
The potential for the international spread of Middle East respiratory syndrome in association with mass gathering events in the Kingdom of Saudi Arabia
Kamran Khan, St. Michael’s Hospital, Toronto, Canada |
| 4:45–5:30: | DISCUSSION |
| 5:30–5:45: | SUMMARY AND CONCLUDING REMARKS |
| 5:50: | ADJOURNMENT |
DAY TWO: WEDNESDAY, MARCH 19, 2014
| 8:30–9:00: | Registration and continental breakfast |
| 9:00–9:15: | Welcome and summary of day one—Dr. David Relman |
| 9:15–10:00: |
KEYNOTE: Lessons learned from IHR implementation and WHO performance in the 2009 (H1N1) influenza pandemic
Harvey V. Fineberg, President, Institute of Medicine |
| 10:00–10:30: | DISCUSSION |
| 10:30–10:45: | BREAK |
SESSION III: DISCUSSION OF THE EMERGENCE OF THE
INFLUENZA A VIRUSES IN ASIA—H5N1, H1N1, H7N9—OTHERS
Moderator: James M. Hughes
| 10:45–11:15: |
Similarities and differences between the novel H7N9 and H5N1 influenza A viruses
Ruben Donis, CDC |
| 11:15–11:45: |
Studies on H7N9 virus infectivity and transmission in poultry and field assessment of epidemiology and control
David Swayne, USDA |
| 11:45–12:15: |
Epidemiology and characteristics of influenza A H7N9 infections
Daniel Jernigan, CDC |
| 12:15–12:45: | DISCUSSION |
| 12:45–1:30: | LUNCH |
SESSION IV: HOW IS THE DOMESTIC AND INTERNATIONAL COMMUNITY RESPONDING TO THESE VIRAL DISEASES?
Moderator: Jeffrey Duchin
| 1:30–2:00: |
Responses to the emergence of H7N9: The OIE perspective
Alex Thiermann, OIE |
| 2:00–2:30: |
Coordinated responses to the emergence of the H7N9 avian influenza A virus in the Asian and Pacific regions—The USAID perspective
Dennis Carroll, USAID |
| 2:30–3:00: |
Challenges in assessing and preventing transmission of β-coronaviruses in hospital/health care facilities
Allison McGeer, Mt. Sinai Hospital, Toronto, Canada |
| 3:00–3:30: | BREAK |
| 3:30–4:00: |
Using what we know from science to contribute to predicting the pandemic potential of zoonotic influenza viruses
Derek Smith, Cambridge (UK) |
| 4:00–4:30: |
A pandemic risk assessment framework to triage animal influenza viruses and minimize pathotyping studies
Ruben Donis, CDC |
| 4:30–5:00: | DISCUSSION |
| 5:00–5:15: | CONCLUDING REMARKS |
| 5:15: | ADJOURNMENT |
